Brain cancer prediction in children is an emerging frontier in the quest for better patient outcomes in pediatric oncology.Recent advancements in artificial intelligence (AI) have shown promise in improving predictions of glioma recurrence risk, a critical challenge for clinicians treating pediatric brain tumors.